Methylation of O6-Methylguanine DNA Methyltransferase and Loss of Heterozygosity on 19q and/or 17p Are Overlapping Features of Secondary Glioblastomas with Prolonged Survival
- 1 May 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (9), 2606-2613
- https://doi.org/10.1158/1078-0432.ccr-06-2184
Abstract
Purpose: Recent data suggest that methylation of the DNA repair gene O6-methylguanine DNA methyltransferase (MGMT), by increasing the chemosensitivity of glioblastoma multiforme, is significantly associated with improved prognosis. Results in contradiction with these findings, however, are present in the literature and the clinical and genetic context framing MGMT methylation is poorly characterized. Experimental Design: To address these issues, we have investigated the MGMT methylation status, clinical and magnetic resonance imaging characteristics, and relevant genetic features (loss of heterozygosity on 17p and 19q, EGFR amplification, and p53 mutations) in a retrospective study on 86 patients affected by glioblastoma multiforme: 72 patients had a clinical history indicating de novo insurgence of the tumor and the remaining 14 were secondary glioblastoma multiforme. Results: MGMT methylation was detected by methylation-specific PCR in 41 of 86 cases (47.7%; Meth+). Progression-free survival and overall survival were significantly longer in Meth+ than in Meth− patients [10 versus 7 months (P = 0.003, log-rank test) and 18 versus 14 months (P = 0.0003, log-rank test), respectively]. Mixed-nodular enhancement at magnetic resonance imaging was significantly more frequent in Meth+ and secondary glioblastoma multiforme and ring enhancement in Meth− and primary glioblastoma multiforme (P < 0.005). MGMT methylation was more present in secondary glioblastoma multiforme (P = 0.006) and associated with loss of heterozygosity on 17p and/or 19q (P = 0.005). Conclusions: These observations suggest that MGMT methylation is part of a genetic signature of glioblastomas that developed from lower-grade gliomas.Keywords
This publication has 37 references indexed in Scilit:
- Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI featuresBrain, 2006
- Reclassification of oligoastrocytomas by loss of heterozygosity studiesInternational Journal of Cancer, 2006
- Magnetic Resonance Imaging Characteristics Predict Epidermal Growth Factor Receptor Amplification Status in GlioblastomaClinical Cancer Research, 2005
- Different angiogenic phenotypes in primary and secondary glioblastomasInternational Journal of Cancer, 2005
- O6-methylguanine-DNA methyltransferase methylation andTP53 mutation in malignant astrocytomas and their relationships with clinical courseInternational Journal of Cancer, 2004
- Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumorsMutation research. Reviews in mutation research, 2004
- Imaging Correlates of Molecular Signatures in OligodendrogliomasClinical Cancer Research, 2004
- DNA repair gene O6‐methylguanine‐DNA methyltransferase: Promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumorsMolecular Carcinogenesis, 2002
- The Molecular and Genetic Basis of Neurological TumoursNature Reviews Cancer, 2002
- A Polymerase Chain Reaction-based Assay for the Rapid Detection of Gene Amplification in Human TumorsDiagnostic Molecular Pathology, 1996